In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »SEARCH RESULT
Petrol consumption may decelerate in FY12 by Amrit Raj
The growth rate of petrol consumption is set to fall below 5% in the current fiscal, the first time in five years. Meanwhile, the consumption of diesel continues to grow at 7%, adding to the losses of the oil marketing companies on account of subsidies. In India, diesel is subsidized while petrol is not, and the price difference has led to more buyers opting for vehicles driven by the cheaper fuel. According...
More »Large-scale exodus of Melghat tribals for jobs-Vaibhav Ganjapure
Ritesh Gautam is a resident of a backward area in Pohara village in Dharni tehsil in Melghat. He migrated to Madhya Pradesh in search of work. Manohar Bode from Seamdoh village went to Solapur for the same reason. Both are back home to celebrate Holi, the biggest festival of tribals. Like Gautam and Bode, there are many youth from the region who left home in search of jobs. They are victims...
More »Change in default law to shield farmer land
-The Telegraph Chief minister Mamata Banerjee has ordered an amendment to a state law to prevent rural co-operative banks from attaching the land of loan-defaulter farmers without government approval. The directive was issued after Mamata came across two posters by a co-operative bank controlled by Trinamul Congress leaders, which sought to auction the land of farmers who have not repaid loans. “I am assuring my brothers that nobody will go to confiscate your...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »